Inogen (INGN) Capital Expenditures Growth (5y) (2018 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Inogen | 165.85 Mn | 71.44 Mn | 37.86 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 22.22% |
| Dec 31, 2025 | -24.41% |
| Sep 30, 2025 | -17.67% |
| Jun 30, 2025 | 20.24% |
| Mar 31, 2025 | -27.71% |
| Dec 31, 2024 | 1.08% |
| Sep 30, 2024 | 42.87% |
| Jun 30, 2024 | -25.28% |
| Mar 31, 2024 | 7.02% |
| Dec 31, 2023 | -19.72% |
| Sep 30, 2023 | 23.27% |
| Jun 30, 2023 | -54.14% |
| Mar 31, 2023 | -49.98% |
| Dec 31, 2022 | 28.49% |
| Sep 30, 2022 | -24.54% |
| Jun 30, 2022 | 47.05% |
| Mar 31, 2022 | -31.26% |
| Dec 31, 2021 | 23.49% |
| Sep 30, 2021 | 36.39% |
| Jun 30, 2021 | 47.02% |
| Mar 31, 2021 | -35.94% |
| Dec 31, 2020 | 16.40% |
| Sep 30, 2020 | 9.68% |
| Jun 30, 2020 | -16.92% |
| Mar 31, 2020 | 21.79% |
| Dec 31, 2019 | 44.80% |
| Sep 30, 2019 | -44.40% |
| Jun 30, 2019 | 19.10% |
| Mar 31, 2019 | 40.73% |
| Dec 31, 2018 | 76.67% |
| Sep 30, 2018 | 3.28% |
| Jun 30, 2018 | -11.66% |
| Mar 31, 2018 | -8.08% |